Stay updated on XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Sign up to get notified when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.

Latest updates to the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a new site, Providence Neurological Specialities in Portland, Oregon (97225). The total number of locations increased from 94 to 95, with the revision updated to v3.5.4.SummaryDifference1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page’s platform/release version tag is updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This represents a minor site maintenance/version update rather than a change to the clinical trial study details.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check75 days agoChange DetectedNew study sites have been added, including Hospital Clínico San Carlos (Madrid), Neurosphera (Warsaw), Prince of Wales Hospital (Randwick), Royal Prince Alfred Hospital (Camperdown), and Austin Epilepsy Care Center (Austin). The total number of locations is updated to 94.SummaryDifference0.6%

- Check104 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.